A Phase I, Open-Label Study to Investigate the Pharmacokinetics and Pharmacodynamics of Etonogestrel (ENG) and 17ß-Estradiol (E2) in Healthy female Postmenarcheal Adolescents and Healthy Female Adults Following Administration of MK-8342B (ENG-E2, 125/300 µg/day) Vaginal Ring
Latest Information Update: 04 Oct 2016
At a glance
- Drugs Estradiol/etonogestrel (Primary)
- Indications Dysmenorrhoea; Pregnancy
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Merck Sharp & Dohme
- 04 Oct 2016 New trial record